Bloks Group Limited — Interim / Quarterly Report 2002

Dec 17, 2001

Listed Company Information

HK PHARMA<00182> - Results Announcement (Summary) Hong Kong Pharmaceutical Holdings Limited announced on 15/12/2001: (stock code: 182) Year end date: 31/3/2002 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/4/2001 from 1/4/2000 to 30/9/2001 to 30/9/2000 ('000) ('000) Turnover : 27,379 13,765 (Loss) from Operations : (17,918) (1,543) Finance cost : (3,064) (2,990) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A (Loss) after Tax & MI : (18,065) (4,533) % Change over Last Period : N/A (LPS)-Basic : (1.32 cents) (0.46 cent) -Diluted : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (18,065) (4,533) Interim Dividend per Share : Nil Nil (Specify if with other options) : - - B/C Dates for Interim Dividend : - Payable Date : - B/C Dates for (-) General Meeting : - Other Distribution for Current Period : - B/C Dates for Other Distribution : - Remarks: 1. BASIS OF PREPARATION The unaudited condensed consolidated interim financial statements are prepared in accordance with Hong Kong Statement of Standard Accounting Practice ("SSAP") No. 25 "Interim Financial Reporting". The accounting policies and basis of preparation used in the preparation of the interim financial statements are the same as those used in the annual audited financial statements for the year ended 31 March 2001, except that the Group has changed certain of its accounting policies following the adoption of the following new or revised SSAPs issued by the Hong Kong Society of Accountants which are effective for accounting periods commencing on or after 1 January 2001: SSAP 9 (revised): Events After the Balance Sheet Date SSAP 14 (revised): Leases (effective for periods commencing on or after 1 July 2000) SSAP 28: Provisions, Contingent Liabilities and Contingent Assets SSAP 29: Intangible Assets SSAP 30: Business Combinations SSAP 31: Impairment of Assets SSAP 32: Consolidated Financial Statements and Accounting for Investments in Subsidiaries Other than lease disclosures and the prior period adjustment, the implementation of the above SSAPs did not have a material impact on the Group's financial statements. 2. COMPARATIVE FIGURES Certain comparative figures in the accounts have been reclassified to conform to the current period's presentation. Amounts of HK$10,517,500 and HK$10,157,500 representing the value of marketable securities sold and purchased were included in turnover and cost of sales, respectively in the unaudited consolidated interim results of the Group for the six months ended 30 September 2000. The Directors redefined the Group's core business and concluded that the trading of marketable securities do not form part of the Group's principal activities. Accordingly, these items were reclassified to other revenue for the prior period interim results. In the opinion of the Directors, these reclassifications in the financial statements provide a better presentation. 3. LOSS PER SHARE The calculation of the basic loss per share is based on the net loss from ordinary activities attributable to shareholders for the period of approximately HK$18,065,000 (2000: HK$4,533,000) and on the weighted average of 1,364,926,753 (2000: 986,869,048 shares) ordinary shares in issue during the period. Diluted loss per share for the six months ended 30 September 2001 and 2000 has not been presented as the effect of the assumed conversion of the share options and the convertible notes of the Company during these periods was anti-dilutive. 4. DIVIDEND The Directors do not recommend the payment of any interim dividend for the six months ended 30 September 2001 (2000: Nil). For more details, please refer to the press announcement today.